BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33431182)

  • 1. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency.
    Morado M; Villegas AM; de la Iglesia S; Martínez-Nieto J; Del Orbe Barreto R; Beneitez D; Salido E;
    Med Clin (Barc); 2021 Sep; 157(5):253.e1-253.e8. PubMed ID: 33431182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How we manage patients with pyruvate kinase deficiency.
    Grace RF; Mark Layton D; Barcellini W
    Br J Haematol; 2019 Mar; 184(5):721-734. PubMed ID: 30681718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular heterogeneity of pyruvate kinase deficiency.
    Bianchi P; Fermo E
    Haematologica; 2020 Sep; 105(9):2218-2228. PubMed ID: 33054047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis, monitoring, and management of pyruvate kinase deficiency in children.
    Johnson S; Grace RF; Despotovic JM
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29696. PubMed ID: 35452178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of pyruvate kinase deficiency in children and adults.
    Grace RF; Barcellini W
    Blood; 2020 Sep; 136(11):1241-1249. PubMed ID: 32702739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.
    Grace RF; Bianchi P; van Beers EJ; Eber SW; Glader B; Yaish HM; Despotovic JM; Rothman JA; Sharma M; McNaull MM; Fermo E; Lezon-Geyda K; Morton DH; Neufeld EJ; Chonat S; Kollmar N; Knoll CM; Kuo K; Kwiatkowski JL; Pospíšilová D; Pastore YD; Thompson AA; Newburger PE; Ravindranath Y; Wang WC; Wlodarski MW; Wang H; Holzhauer S; Breakey VR; Kunz J; Sheth S; Rose MJ; Bradeen HA; Neu N; Guo D; Al-Sayegh H; London WB; Gallagher PG; Zanella A; Barcellini W
    Blood; 2018 May; 131(20):2183-2192. PubMed ID: 29549173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual pyruvate kinase activity in PKLR-deficient erythroid precursors of a patient suffering from severe haemolytic anaemia.
    Klei TRL; Kheradmand Kia S; Veldthuis M; Beuger BM; Geissler J; Dehbozorgian J; Karimi M; van Bruggen R; van Zwieten R
    Eur J Haematol; 2017 Jun; 98(6):584-589. PubMed ID: 28295642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell pyruvate kinase deficiency in Spain: A study of 15 cases.
    Montllor L; Mañú-Pereira MD; Llaudet-Planas E; Gómez Ramírez P; Sevilla Navarro J; Vives-Corrons JL
    Med Clin (Barc); 2017 Jan; 148(1):23-27. PubMed ID: 27871768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemolytic anemia associated with a novel heterozygote mutation 1183A in the PK-LR gene (PK- Jordan).
    Karadsheh NS; Gelbart T; Naffa RG
    Int J Lab Hematol; 2014 Aug; 36(4):e66-8. PubMed ID: 24330591
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular genetic testing enabled the diagnosis of otherwise undiagnosable cases of pyruvate kinase deficiency.
    Chueh HW; Kim N
    Pediatr Hematol Oncol; 2022 Mar; 39(2):166-173. PubMed ID: 34281465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates and advances in pyruvate kinase deficiency.
    Luke N; Hillier K; Al-Samkari H; Grace RF
    Trends Mol Med; 2023 May; 29(5):406-418. PubMed ID: 36935283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case With Pyruvate Kinase Deficiency Remarkably Sensitive to Heat.
    Aksu T; Yarali N; Fermo E; Marcello A; Hacisalihoğlu Ş; Bianchi P; Özbek NY
    J Pediatr Hematol Oncol; 2018 Oct; 40(7):e458-e460. PubMed ID: 29309376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of pyruvate kinase deficiency: international expert guidelines.
    Al-Samkari H; Shehata N; Lang-Robertson K; Bianchi P; Glenthøj A; Sheth S; Neufeld EJ; Rees DC; Chonat S; Kuo KHM; Rothman JA; Barcellini W; van Beers EJ; Pospíšilová D; Shah AJ; van Wijk R; Glader B; Mañú Pereira MDM; Andres O; Kalfa TA; Eber SW; Gallagher PG; Kwiatkowski JL; Galacteros F; Lander C; Watson A; Elbard R; Peereboom D; Grace RF
    Lancet Haematol; 2024 Mar; 11(3):e228-e239. PubMed ID: 38330977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Who should be eligible for gene therapy clinical trials in red blood cell pyruvate kinase deficiency (PKD)?: Toward an expanded definition of severe PKD.
    Schwartz JD; Barcellini W; Grace RF; Bianchi P; Zanella A; López Lorenzo JL; Sevilla J; Shah AJ; Glader B; Nicoletti E; Navarro Ordoñez S; Segovia JC
    Am J Hematol; 2022 Mar; 97(3):E120-E125. PubMed ID: 34989415
    [No Abstract]   [Full Text] [Related]  

  • 15. Addressing the diagnostic gaps in pyruvate kinase deficiency: Consensus recommendations on the diagnosis of pyruvate kinase deficiency.
    Bianchi P; Fermo E; Glader B; Kanno H; Agarwal A; Barcellini W; Eber S; Hoyer JD; Kuter DJ; Maia TM; Mañu-Pereira MDM; Kalfa TA; Pissard S; Segovia JC; van Beers E; Gallagher PG; Rees DC; van Wijk R;
    Am J Hematol; 2019 Jan; 94(1):149-161. PubMed ID: 30358897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [From gene to disease; hereditary non-spherocytic hemolytic anemia caused by pyruvate kinase deficiency].
    de Vooght KM; van Wijk R; Nieuwenhuis HK; Ploos van Amstel JK; Rijksen G; van Solinge WW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1828-31. PubMed ID: 12382367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyruvate kinase deficiency in children.
    Chonat S; Eber SW; Holzhauer S; Kollmar N; Morton DH; Glader B; Neufeld EJ; Yaish HM; Rothman JA; Sharma M; Ravindranath Y; Wang H; Breakey VR; Sheth S; Bradeen HA; Al-Sayegh H; London WB; Grace RF
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29148. PubMed ID: 34125488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The variable manifestations of disease in pyruvate kinase deficiency and their management.
    Al-Samkari H; Van Beers EJ; Kuo KHM; Barcellini W; Bianchi P; Glenthøj A; Del Mar Mañú Pereira M; Van Wijk R; Glader B; Grace RF
    Haematologica; 2020 Sep; 105(9):2229-2239. PubMed ID: 33054048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyruvate kinase deficiency child with novel PK-LR gene mutations was successfully cured by matched unrelated donor peripheral blood stem cell transplantation.
    Zhan LP; Que LP; Wu ZZ; Liu DD; Wang KM; Xu HG; Fang JP; Huang K
    Pediatr Transplant; 2021 Nov; 25(7):e14078. PubMed ID: 34255916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pyruvate kinase (PK) to hexokinase enzyme activity ratio and erythrocyte PK protein level in the diagnosis and phenotype of PK deficiency.
    Al-Samkari H; Addonizio K; Glader B; Morton DH; Chonat S; Thompson AA; Kuo KHM; Ravindranath Y; Wang H; Rothman JA; Kwiatkowski JL; Kung C; Kosinski PA; Al-Sayegh H; London WB; Grace RF
    Br J Haematol; 2021 Mar; 192(6):1092-1096. PubMed ID: 32463523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.